ATSE:MEDIC

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Market Cap

€11.0m

Last Updated

2021/07/31 16:22 UTC

Data Sources

Company Financials

Executive Summary

Medicon Hellas S.A. operates in the diagnostics industry. More Details


Snowflake Analysis

Undervalued with excellent balance sheet.

Share Price & News

How has Medicon Hellas's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: MEDIC is not significantly more volatile than the rest of Greek stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: MEDIC's weekly volatility (5%) has been stable over the past year.


Market Performance


7 Day Return

2.1%

MEDIC

1.1%

GR Medical Equipment

2.8%

GR Market


1 Year Return

38.5%

MEDIC

28.8%

GR Medical Equipment

-14.7%

GR Market

Return vs Industry: MEDIC exceeded the Greek Medical Equipment industry which returned 28.6% over the past year.

Return vs Market: MEDIC exceeded the Greek Market which returned -13.4% over the past year.


Shareholder returns

MEDICIndustryMarket
7 Day2.1%1.1%2.8%
30 Day8.8%6.4%-0.6%
90 Day18.1%9.1%-2.8%
1 Year38.5%38.5%30.3%28.8%-13.2%-14.7%
3 Year83.7%83.7%65.3%58.9%-47.3%-49.2%
5 Year213.9%213.9%160.8%141.1%-39.8%-42.9%

Long-Term Price Volatility Vs. Market

How volatile is Medicon Hellas's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Medicon Hellas undervalued compared to its fair value and its price relative to the market?

22.4%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: MEDIC (€2.48) is trading below our estimate of fair value (€3.19)

Significantly Below Fair Value: MEDIC is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: MEDIC is good value based on its PE Ratio (14.5x) compared to the European Medical Equipment industry average (38.3x).

PE vs Market: MEDIC is good value based on its PE Ratio (14.5x) compared to the Greek market (21.1x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate MEDIC's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: MEDIC is good value based on its PB Ratio (1x) compared to the XE Medical Equipment industry average (5.2x).


Future Growth

How is Medicon Hellas forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

17.1%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Medicon Hellas has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Medicon Hellas performed over the past 5 years?

-21.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: MEDIC has high quality earnings.

Growing Profit Margin: MEDIC's current net profit margins (5%) are lower than last year (5.7%).


Past Earnings Growth Analysis

Earnings Trend: MEDIC's earnings have declined by 21.1% per year over the past 5 years.

Accelerating Growth: MEDIC's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: MEDIC had negative earnings growth (-1.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (40.8%).


Return on Equity

High ROE: MEDIC's Return on Equity (7%) is considered low.


Financial Health

How is Medicon Hellas's financial position?


Financial Position Analysis

Short Term Liabilities: MEDIC's short term assets (€17.7M) exceed its short term liabilities (€3.9M).

Long Term Liabilities: MEDIC's short term assets (€17.7M) exceed its long term liabilities (€13.0M).


Debt to Equity History and Analysis

Debt Level: MEDIC's debt to equity ratio (103.6%) is considered high.

Reducing Debt: MEDIC's debt to equity ratio has reduced from 416.8% to 103.6% over the past 5 years.

Debt Coverage: MEDIC's debt is well covered by operating cash flow (25.4%).

Interest Coverage: MEDIC's interest payments on its debt are well covered by EBIT (21.9x coverage).


Balance Sheet


Dividend

What is Medicon Hellas's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate MEDIC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MEDIC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if MEDIC's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MEDIC's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: MEDIC is not paying a notable dividend for the Greek market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of MEDIC's dividend in 3 years as they are not forecast to pay a notable one for the Greek market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Maria Dimotsantou Sotiriou (68 yo)

no data

Tenure

Ms. Maria Dimotsantou Sotiriou has been the Chairman of the Board and Chief Executive Officer of Medicon Hellas S.A. since October 31, 2014. Ms. Dimotsantou Sotiriou speaks English.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Medicon Hellas S.A.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Medicon Hellas S.A.
  • Ticker: MEDIC
  • Exchange: ATSE
  • Founded: 1988
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: €10.961m
  • Shares outstanding: 4.42m
  • Website: https://www.mediconsa.com

Number of Employees


Location

  • Medicon Hellas S.A.
  • Melitona 5-7
  • Gerakas
  • 153 44
  • Greece

Listings


Biography

Medicon Hellas S.A. operates in the diagnostics industry. The company offers instruments, tests, and procedures for public and private hospitals, primary care centers, diagnostic centers, and private labor...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/07/31 16:22
End of Day Share Price2021/07/30 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.